RheoSense

RheoSense is a privately held instrumentation company that has established itself as a leader in micro-volume viscometry through its innovative VROC chip technology. The company's products, including the m-VROC II and the automated VROC initium 1++ HTscreen, address critical needs in biopharmaceutical development, particularly for characterizing protein therapeutics, gene therapies, and other complex fluids where sample volume is limited. By combining hardware, software, consumables, and contract testing services, RheoSense provides a comprehensive solution for R&D and QC labs seeking reliable, high-shear viscosity data. Its business model is built on capital equipment sales, recurring consumables revenue, and fee-for-service sample testing.

VROC (Viscometer/Rheometer-on-a-Chip) - a MEMS-based microfluidic platform for measuring absolute viscosity from ultra-small sample volumes (as low as 15µL) at high shear rates.

RheoSense competes in the niche of micro-volume viscometry against traditional viscometer/rheometer manufacturers like Anton Paar and TA Instruments (Waters), which offer macro-volume systems. It also faces potential competition from other microfluidic or lab-on-a-chip startups. Its primary competitive edge is its patented VROC chip technology, which offers a unique combination of very small sample size, high shear rate capability, and absolute measurement without calibration.